Lack of Specificity of Anticyclic Citrullinated Peptide Antibodies in Advanced Human Immunodeficiency Virus Infection
Lack of Specificity of Anticyclic Citrullinated Peptide Antibodies in Advanced Human Immunodeficiency Virus Infection
复制标题
DOI:
10.3899/jrheum.100713
复制
发表时间:
2011-06-01
影响因子:
3.9
通讯作者:
Esser, Monika
中科院分区:
文献类型:
--
作者:
du Toit, Riette;Whitelaw, David;Esser, Monika
Objective. To determine the prevalence and specificity of anticyclic citrullinated peptide antibodies (anti-CCP) and rheumatoid factor (RF) for rheumatoid arthritis (RA) in human immunodeficiency virus (HIV) infection and to evaluate the effect of immune reconstitution on these markers.Methods. Patients with advanced HIV infection without arthritis were enrolled. CD4+ T lymphocyte counts (CD4), anti-CCP, and RF were determined before initiating antiretroviral therapy (ART) and repeated after 6 months. Results were compared to those of healthy controls. Patients were followed for the development of RA for I year.Results. Sixty patients and 26 controls were studied. Six-month followup results were available on 49 patients. Mean (SD) levels of anti-CCP were higher in patients with HIV compared to controls: respectively, 9.50 (11.41) versus 0.80 (1.32) units (p